Hepatocellular Carcinoma in a Patient with Hereditary Hemorrhagic Telangiectasia

Intern Med. 2018 Dec 15;57(24):3545-3549. doi: 10.2169/internalmedicine.1056-18. Epub 2018 Aug 24.

Abstract

A 76-year-old woman with hereditary hemorrhagic telangiectasia (HHT) showed elevated serum hepatobiliary enzyme levels, and abdominal imaging studies revealed a hepatic tumor. Her serum alpha-fetoprotein level was 759.5 ng/mL. A pathological examination after hepatectomy confirmed a diagnosis of hepatocellular carcinoma (HCC). An examination of the surrounding liver revealed dilated vessels and thickened endothelial cells without inflammations. HHT patients without other risk factors (like this patient) reportedly have a lower incidence of common cancers, including HCC, in comparison to the unaffected population. One intriguing hypothesis that might explain the hepatocarcinogenesis in this situation is the ischemic liver cirrhosis theory, which suggests that chronic ischemia may cause parenchymal strain and promote inappropriate hepatocyte proliferation.

Keywords: focal nodular hyperplasia; hepatocellular carcinoma; hereditary hemorrhagic telangiectasia; ischemic liver cirrhosis theory; vascular malformation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / diagnosis*
  • Diagnosis, Differential
  • Endoscopy, Gastrointestinal
  • Fatal Outcome
  • Female
  • Humans
  • Liver Neoplasms / complications
  • Liver Neoplasms / diagnosis*
  • Magnetic Resonance Imaging
  • Telangiectasia, Hereditary Hemorrhagic / complications*
  • Telangiectasia, Hereditary Hemorrhagic / diagnosis
  • Tomography, X-Ray Computed